![](https://www.diabetesnews.com/wp-content/uploads/2014/05/pill-78915b8cd74585c6c282cabd78b904bc4a708dd8-s6-c30-150x150.jpg)
GLP-1 Victoza reduces the risk of death from heart disease, kidney disease, hypoglycemia, severe hypoglycemia, and other complications in people with type 2 diabetes at high risk for heart disease.
GLP-1 Victoza reduces the risk of death from heart disease, kidney disease, hypoglycemia, severe hypoglycemia, and other complications in people with type 2 diabetes at high risk for heart disease.